作者: A. G. Smith , J. M. Whitehouse , O. S. Roath , C. J. Williams , G. M. Mead
DOI: 10.1007/978-3-642-71213-5_51
关键词: Myeloid leukaemia 、 Older patients 、 Leukemia 、 Medicine 、 Palliative care 、 Myeloid 、 Remission induction 、 Palliative Therapy 、 Internal medicine 、 Acute leukemia
摘要: Most patients with acute myeloid leukaemia (AML) are over 60 years old [1], remission rates lower and survival poorer for this group in both AML [2] older lymphocytic (ALL) [3]. Current intensive therapy protocols have been proposed as the treatment of choice these although published studies advocating approach contain a percentage than would otherwise be expected [4, 5]. Such therefore do not appear to reflect whole problem elderly.